A review on synthetic methods for 2-Deoxy-D-glucose
| dc.contributor.author | Gupta, Vidushi | |
| dc.date.accessioned | 2023-08-11T10:42:05Z | |
| dc.date.available | 2023-08-11T10:42:05Z | |
| dc.date.issued | 2022 | |
| dc.description | Only IISER Mohali authors are available in the record. | en_US |
| dc.description.abstract | 2-Deoxy-D-glucose (2-DG) is a non-metabolizable glucose analog that has shown promising pharmacological activities and has been used to study the role of glucose in cancer cells. 2-DG is an inhibitor of glycolysis, potential Energy Restriction Mimetic agent and inhibits pathogen-associated molecular patterns. Its radioisotope derivatives have application as tracers. Recently, 2-DG has been used as an anti-COVID-19 drug lowering the need for supplemental oxygen. In this review, different synthetic strategies for preparation of 2- DG including enzymatic synthesis have been discussed. The understanding of these methods would help in developing therapeutics or diagnostic agents aimed at exploring therapeutic targets related with energy metabolism. | en_US |
| dc.identifier.citation | Arkivoc, 2022(6), 199-219 | en_US |
| dc.identifier.uri | https://doi.org/10.24820/ark.5550190.p011.946 | |
| dc.identifier.uri | http://hdl.handle.net/123456789/4522 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | ARKAT USA | en_US |
| dc.subject | 2-DG | en_US |
| dc.subject | COVID-19 | en_US |
| dc.subject | Warburg effect | en_US |
| dc.subject | aerobic glycolysis | en_US |
| dc.title | A review on synthetic methods for 2-Deoxy-D-glucose | en_US |
| dc.type | Article | en_US |